Gyre Therapeutics, Inc. GYRE Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Madrigal Pharmaceuticals, Inc.MDGL

$12.46B+98.7%

Viking TherapeuticsVKTX

$3.81B-14.5%

Theravance BiopharmaTBPH

$699.88M+135%

Rigel PharmaceuticalsRIGL

$543.41M+96.3%

Zevra Therapeutics, Inc.ZVRA

$703.89M+36.7%

FAQ

What is Gyre Therapeutics, Inc.'s enterprise value?

Gyre Therapeutics, Inc. (GYRE) reported enterprise value of $694.84M in Q2 2026.

How has Gyre Therapeutics, Inc.'s enterprise value changed year-over-year?

Gyre Therapeutics, Inc.'s enterprise value increased by 6.1% year-over-year, from $654.8M to $694.84M.

What is the long-term trend for Gyre Therapeutics, Inc.'s enterprise value?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s enterprise value has grown at a -42.8% compound annual growth rate (CAGR), from $1.93B to $631.86M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.